Littérature scientifique sur le sujet « Vaccines Effectiveness »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Vaccines Effectiveness ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Vaccines Effectiveness"
Trombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani et Serena Marchi. « Influenza Viruses and Vaccines : The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines ». Vaccines 10, no 5 (1 mai 2022) : 714. http://dx.doi.org/10.3390/vaccines10050714.
Texte intégralHelena De Oliveira, Lucia, Barbara Jauregui, Ana Flavia Carvalho et Norberto Giglio. « Impact and effectiveness of meningococcal vaccines : a review ». Revista Panamericana de Salud Pública 41 (20 décembre 2017) : 1. http://dx.doi.org/10.26633/rpsp.2017.158.
Texte intégralPálinkás, Anita, et János Sándor. « Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary : Nationwide Retrospective Cohort Study ». Vaccines 10, no 7 (24 juin 2022) : 1009. http://dx.doi.org/10.3390/vaccines10071009.
Texte intégralKamolratanakul, Supitcha, et Punnee Pitisuttithum. « Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer ». Vaccines 9, no 12 (30 novembre 2021) : 1413. http://dx.doi.org/10.3390/vaccines9121413.
Texte intégralIzurieta, Hector S., Yoganand Chillarige, Jeffrey Kelman, Yuqin Wei, Yun Lu, Wenjie Xu, Michael Lu et al. « Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019 ». Journal of Infectious Diseases 222, no 2 (26 février 2020) : 278–87. http://dx.doi.org/10.1093/infdis/jiaa080.
Texte intégralDiogo José Horst et Charles Adriano Duvoisin. « The doubtful effectiveness of the COVID-19 vaccine ». GSC Biological and Pharmaceutical Sciences 15, no 2 (30 mai 2021) : 151–57. http://dx.doi.org/10.30574/gscbps.2021.15.2.0132.
Texte intégralKnight-Jones, T. J. D., K. Edmond, S. Gubbins et D. J. Paton. « Veterinary and human vaccine evaluation methods ». Proceedings of the Royal Society B : Biological Sciences 281, no 1784 (7 juin 2014) : 20132839. http://dx.doi.org/10.1098/rspb.2013.2839.
Texte intégralStöckli, Sabrina, Anna Katharina Spälti, Joseph Phillips, Florian Stoeckel, Matthew Barnfield, Jack Thompson, Benjamin Lyons, Vittorio Mérola, Paula Szewach et Jason Reifler. « Which vaccine attributes foster vaccine uptake ? A cross-country conjoint experiment ». PLOS ONE 17, no 5 (4 mai 2022) : e0266003. http://dx.doi.org/10.1371/journal.pone.0266003.
Texte intégralErofeeva, M. K., M. A. Stukova, E. V. Shakhlanskaya, Zh V. Buzitskaya, V. L. Maksakova, T. I. Krainova, M. M. Pisareva, A. B. Popov, M. G. Pozdnjakova et D. A. Lioznov. « Evaluation of the Preventive Effectiveness of Influenza Vaccines in the Epidemic Season 2019–2020 in St. Petersburg ». Epidemiology and Vaccinal Prevention 20, no 5 (5 novembre 2021) : 52–60. http://dx.doi.org/10.31631/2073-3046-2021-20-5-52-60-52-60.
Texte intégralRajaram, Sankarasubramanian, Constantina Boikos, Daniele K. Gelone et Ashesh Gandhi. « Influenza vaccines : the potential benefits of cell-culture isolation and manufacturing ». Therapeutic Advances in Vaccines and Immunotherapy 8 (janvier 2020) : 251513552090812. http://dx.doi.org/10.1177/2515135520908121.
Texte intégralThèses sur le sujet "Vaccines Effectiveness"
Ming, Wai-kit, et 明偉傑. « Effectiveness of universal rotavirus vaccination : a literature review ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B50222995.
Texte intégralpublished_or_final_version
Public Health
Master
Master of Public Health
Boros, Christina Ann. « Factors affecting the immunogenicity and protective efficacy of routine childhood immunisations ». Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phb736.pdf.
Texte intégralYuen, Wing-mei, et 阮泳薇. « Systematic review on the cost effectiveness of human papillomavirus vaccination in Asia and its implication in Hong Kong ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48427329.
Texte intégralpublished_or_final_version
Public Health
Master
Master of Public Health
Cheung, Ka-mei Camy, et 張嘉楣. « The cost-effectiveness of human pappillomavirus vaccines in men : a systematic review ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193771.
Texte intégralpublished_or_final_version
Community Medicine
Master
Master of Public Health
Lau, Tin-wai. « Effectiveness of influenza vaccine among elderly people living in residential care homes during outbreak situations ». Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/b39724177.
Texte intégralMezones, Holguín Edward, Díaz Rafael Bolaños, Víctor Fiestas, César Sanabria, Aguado Alfonso Gutiérrez, Fabián Fiestas, Víctor J. Suárez, Morales Alfonso J. Rodríguez et Adrian V. Hernández. « Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children ». The Journal of Infection in Developing Countries, 2015. http://hdl.handle.net/10757/337985.
Texte intégralIntroduction: Pneumococcal pneumonia (PP) has a high burden of morbimortality in children. Use of pneumococcal conjugate vaccines (PCVs) is an effective preventive measure. After PCV 7-valent (PCV7) withdrawal, PCV 10-valent (PCV10) and PCV 13-valent (PCV13) are the alternatives in Peru. This study aimed to evaluate cost effectiveness of these vaccines in preventing PP in Peruvian children <5 yearsold. Methodology: A cost-effectiveness analysis was developed in three phases: a systematic evidence search for calculating effectiveness; a cost analysis for vaccine strategies and outcome management; and an economic model based on decision tree analysis, including deterministic and probabilistic sensitivity analysis using acceptability curves, tornado diagram, and Monte Carlo simulation. A hypothetic 100 vaccinated children/vaccine cohort was built. An incremental cost-effectiveness ratio (ICER) was calculated. Results: The isolation probability for all serotypes in each vaccine was estimated: 38% for PCV7, 41% PCV10, and 17% PCV13. Avoided hospitalization was found to be the best effectiveness model measure. Estimated costs for PCV7, PCV10, and PCV13 cohorts were USD13,761, 11,895, and 12,499, respectively. Costs per avoided hospitalization were USD718 for PCV7, USD333 for PCV10, andUSD 162 for PCV13. At ICER, PCV7 was dominated by the other PCVs. Eliminating PCV7, PCV13 was more cost effective than PCV10 (confirmed in sensitivity analysis). Conclusions: PCV10 and PCV13 are more cost effective than PCV7 in prevention of pneumonia in children <5 years-old in Peru. PCV13 prevents more hospitalizations and is more cost-effective than PCV10. These results should be considered when making decisions about the Peruvian National Inmunizations Schedule.
This study was funded by Instituto Nacional de Salud, Lima, Peru
Revisión pór pares
Mezones, Holguín Edward, Aybara Carlos Canelo, Clark Andrew David, Janusz Cara Bess, Bárbara Jaúregui, Palza Seimer Escobedo, Adrian V. Hernandez et al. « Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru ». Elsevier B.V, 2015. http://hdl.handle.net/10757/582635.
Texte intégralThis study was presented at 9th International Symposium of Pneumococci and Pneumococcal Diseases, Hyderabad, India, March 2014, and supported by the National Council of Science, Technology and Technological Innovation of Peru (CONCYTEC) and International Clinical Epidemiology Network (INCLEN Trust)
This study was made possible through the financial support of the Instituto Nacional de Salud (National Institute of Health, Lima, Peru) and the PROVAC Initiative of the Pan American Health Organization (Washington, DC, USA).
Marlow, Robin. « Assessing the impact and cost-effectiveness of rotavirus vaccines in the United Kingdom ». Thesis, University of Bristol, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705468.
Texte intégralSharma, Aditya. « Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates ». Yale University, 2008. http://ymtdl.med.yale.edu/theses/available/etd-08272007-114829/.
Texte intégralKoh, Naoko. « Cost-benefit analysis of influenza vaccination for children in Hong Kong ». Thesis, Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971866.
Texte intégralLivres sur le sujet "Vaccines Effectiveness"
Sullivan, Louis Wade. Cost-effectiveness demonstration of Medicare coverage of influenza vaccine : Report to Congress. [Washington, D.C. ? : Dept. of Health and Human Services], 1990.
Trouver le texte intégralShalala, Donna E. Medicare influenza vaccine demonstration : Report to Congress. [Washington, D.C. ? : Dept. of Health and Human Services], 1993.
Trouver le texte intégralChan, Kwai-Cheung. Medical readiness : Issues concerning the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013) : The Office, 1999.
Trouver le texte intégralChan, Kwai-Cheung. Medical readiness : Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C : The Office, 1999.
Trouver le texte intégralChan, Kwai-Cheung. Medical readiness : Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C : The Office, 1999.
Trouver le texte intégralTaehak, Sŏul Taehakkyo Ŭikwa, dir. Inpʻŭlluenja paeksin (soa) yuyongsŏng pʻyŏngka yŏnʼgu : Yŏnʼgu kyŏlgwa pogosŏ = Evaluation of efficacy of influenza vaccine in children. [Seoul] : Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.
Trouver le texte intégralCommunicating about Vaccine Safety : Guidelines to help health workers communicate with parents, caregivers, and patients. Pan American Health Organization, 2021. http://dx.doi.org/10.37774/9789275122822.
Texte intégralBarker, Richard. Lessons from the last 20 years. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198737780.003.0004.
Texte intégralRouse, Carolyn. Evidence of What ? Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190465285.003.0010.
Texte intégralR, Berndt Ernst, et National Bureau of Economic Research., dir. Advanced purchase commitments for a malaria vaccine : Estimating costs and effectiveness. Cambridge, MA : National Bureau of Economic Research, 2005.
Trouver le texte intégralChapitres de livres sur le sujet "Vaccines Effectiveness"
Myers, Evan R. « Cost-Effectiveness of HPV Vaccines ». Dans Emerging Issues on HPV Infections, 235–41. Basel : KARGER, 2006. http://dx.doi.org/10.1159/000092759.
Texte intégralWhitney, Cynthia G., et Matthew R. Moore. « Direct and Indirect Effectiveness and Safety of Pneumococcal Conjugate Vaccine in Practice ». Dans Pneumococcal Vaccines, 351–68. Washington, DC, USA : ASM Press, 2014. http://dx.doi.org/10.1128/9781555815820.ch24.
Texte intégralBiggers, John D. « The Potential Effectiveness and Safety of Second Generation Vaccines ». Dans Immunological Approaches to Contraception and Promotion of Fertility, 203–7. Boston, MA : Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5140-5_24.
Texte intégralLehtinen, Matti, Pekka Nieminen, Dan Apter, Proscowa Namujju, Kari Natunen, Mohsin Rana et Jorma Paavonen. « Immunogenicity, Efficacy, Effectiveness and Overall Impact of HPV Vaccines ». Dans HPV and Cervical Cancer, 257–72. New York, NY : Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1988-4_10.
Texte intégralBora, Ajitabh, Hemanta Kumar Gogoi et Vijay Veer. « Molecular Farming for Production of Biopharmaceuticals and Edible Vaccines in Plants ». Dans Herbal Insecticides, Repellents and Biomedicines : Effectiveness and Commercialization, 205–16. New Delhi : Springer India, 2016. http://dx.doi.org/10.1007/978-81-322-2704-5_11.
Texte intégralMueller, Siguna. « The Challenge of Evaluating Vaccine Safety and Effectiveness ». Dans Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2, 131–62. Cham : Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-18903-6_5.
Texte intégralHahné, Susan, Kaatje Bollaerts et Paddy Farrington. « Vaccine effectiveness ». Dans Vaccination Programmes, 223–44. London : Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-16.
Texte intégralNauta, Jozef. « Vaccine Effectiveness Studies ». Dans Springer Series in Pharmaceutical Statistics, 129–50. Cham : Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-37693-2_9.
Texte intégralHahné, Susan, Kaatje Bollaerts et Paddy Farrington. « Estimating vaccine effectiveness ». Dans Vaccination Programmes, 289–308. London : Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-19.
Texte intégralHahné, Susan, Kaatje Bollaerts et Paddy Farrington. « Estimating vaccine effectiveness ». Dans Vaccination Programmes, 245–63. London : Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-17.
Texte intégralActes de conférences sur le sujet "Vaccines Effectiveness"
Zughaier, Susu. « High Vaccine Coverage is Crucial for Preventing the Spread of Infectious Diseases During Mass Gathering ». Dans Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0138.
Texte intégral« Emergence of SARS-CoV-2 Variant of Concern Omicron : Biological Features and Genomic Concern ». Dans International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/itrx2370.
Texte intégralDitamy, Aldila, Beatrice Sasmita, Bella Edytha Kurniawan, I. Putu Indra Widia Kumara, Nathanael Victorius, Shreyasi Sarkar et Bagus Mulyawan. « The Effectiveness, Side Effects, and Implementation Between Variation of COVID-19 Vaccines in Indonesia ». Dans 3rd Tarumanagara International Conference on the Applications of Social Sciences and Humanities (TICASH 2021). Paris, France : Atlantis Press, 2022. http://dx.doi.org/10.2991/assehr.k.220404.303.
Texte intégralIgnatova, G., V. Antonov et E. Blinova. « Effectiveness of Joint or Sequential Vaccination of Pneumococcal and Flu Vaccines in Chronic Obstructive Pulmonary Disease Patients ». Dans American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3317.
Texte intégralXiao, Yichen, Han-Ching Ou, Haipeng Chen, Van Thieu Nguyen et Long Tran-Thanh. « Sequential Vaccine Allocation with Delayed Feedback ». Dans Thirty-First International Joint Conference on Artificial Intelligence {IJCAI-22}. California : International Joint Conferences on Artificial Intelligence Organization, 2022. http://dx.doi.org/10.24963/ijcai.2022/722.
Texte intégralSikjær, M., M. S. Wik, S. S. Stensholt, O. Hilberg et A. Løkke. « Effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease : A systematic search and review of the literature ». Dans ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.793.
Texte intégralCapão, Artur, Braulia Caetano, Paola Resende, Milene Miranda, David Brown, Marilda Siqueira et Cristiana Garcia. « Effectiveness of 2018 trivalent influenza vaccine on healthcare professionals ». Dans IV International Symposium on Immunobiologicals & VII Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2019. http://dx.doi.org/10.35259/isi.sact.2019_32545.
Texte intégralElbashir, Israa, Aisha Aisha Nasser J. M. Al-Saei, Paul Thornalley et Naila Rabbani. « Evaluation of antiviral activity of Manuka honey against SARS-CoV-2. » Dans Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0113.
Texte intégralAdami, Giovanni, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti et Maurizio Rossini. « OP0230 EFFECTIVENESS OF INFLUENZA VACCINE IN TNF INHIBITORS TREATED PATIENTS ». Dans Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3088.
Texte intégralVasileiou, Eleftheria, Colin Simpson, Aziz Sheikh et Chris Butler. « Seasonal influenza vaccine effectiveness in people with asthma : A systematic review ». Dans ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa4205.
Texte intégralRapports d'organisations sur le sujet "Vaccines Effectiveness"
Ketata, Imen, Rahma Sellami, Marwa Gargouri, Leila Zrelli, Hajer Azzouzi et Houda Ghorbel. Effectiveness of COVID-19 vaccines in older adults in South Tunisia-Gabes. Peeref, octobre 2022. http://dx.doi.org/10.54985/peeref.2210p5297898.
Texte intégralRoldan de Jong, Tamara. Rapid Review : Perceptions of COVID-19 Vaccines in South Africa. SSHAP, avril 2022. http://dx.doi.org/10.19088/sshap.2021.021.
Texte intégralMillington, Kerry A. Protecting and Promoting Systems for Essential Health Services During Rollout of COVID-19 Tools. Institute of Development Studies (IDS), mai 2021. http://dx.doi.org/10.19088/k4d.2021.084.
Texte intégralBerndt, Ernst, Rachel Glennerster, Michael Kremer, Jean Lee, Ruth Levine, Georg Weizsacker et Heidi Williams. Advanced Purchase Commitments for a Malaria Vaccine : Estimating Costs and Effectiveness. Cambridge, MA : National Bureau of Economic Research, mai 2005. http://dx.doi.org/10.3386/w11288.
Texte intégralAlsan, Marcella, et Sarah Eichmeyer. Experimental Evidence on the Effectiveness of Non-Experts for Improving Vaccine Demand. Cambridge, MA : National Bureau of Economic Research, mars 2021. http://dx.doi.org/10.3386/w28593.
Texte intégralButler, Nadia, et Soha Karam. Key Considerations for Integrating COVID-19 Vaccination Services : Insights from Iraq and Syria for the MENA Region. SSHAP, septembre 2022. http://dx.doi.org/10.19088/sshap.2022.034.
Texte intégralRussell, Kevin L., Margaret A. Ryan, Anthony Hawksworth, Nikki E. Freed, Marina Irvine et Luke T. Daum. Effectiveness of the 2003/2004 Influenza Vaccine Among U.S. Military Basic Trainees : A Year of Suboptimal Match Between Vaccine and Circulating Strain. Fort Belvoir, VA : Defense Technical Information Center, juin 2004. http://dx.doi.org/10.21236/ada455912.
Texte intégralParis, Chloe, Julie Spencer, Lauren Castro et Sara Del Valle. Exploring Impacts to COVID-19 Herd Immunity Thresholds Under Demographic Heterogeneity that Lowers Vaccine Effectiveness. Office of Scientific and Technical Information (OSTI), juin 2022. http://dx.doi.org/10.2172/1874147.
Texte intégralXu, Junjie, Jiaye Liu, Xinquan Lan, Moxin Song, Liangyuan Zhang et Jiaqi Zhang. Efficacy of the third dose of COVID-19 vaccine : a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, novembre 2022. http://dx.doi.org/10.37766/inplasy2022.11.0114.
Texte intégralLamont, Susan J., E. Dan Heller et Avigdor Cahaner. Prediction of Immunocompetence and Resistance to Disease by Using Molecular Markers of the Major Histocompatibility Complex. United States Department of Agriculture, septembre 1994. http://dx.doi.org/10.32747/1994.7568780.bard.
Texte intégral